Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioadaptives Inc (BDPTD)

Bioadaptives Inc (BDPTD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing

LAS VEGAS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT) today announced the commercial availability of MyndMedâ„¢ , a next-generation cognitive-support dietary supplement...

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety

LAS VEGAS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTCMKTS: BDPT), a leader in natural health and performance supplements, today announced that its flagship nootropic formula,...

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience

LAS VEGAS, July 16, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), an innovator in evidence-based wellness solutions, today announced the upcoming national release of NeuroRushâ„¢ , a next-generation...

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Announces National Launch of Pawpaâ„¢ Regen

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors

BDPT : 0.0281 (+27.73%)
BDPTD : 0.1089 (-1.00%)
BioAdaptives Announces FINRA Approval of a Dividend for Common Stock Shareholders

BDPTD : 0.1089 (-1.00%)
BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health

BDPTD : 0.1089 (-1.00%)

Barchart Exclusives

Stocks Slip Before the Open as Investors Weigh Trump Policy Shifts, U.S. Economic Data on Tap
March S&P 500 E-Mini futures (ESH26) are down -0.19%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.28% this morning, pointing to further losses on Wall Street as investors digest a flurry of announcements from U.S. President Donald Trump on the U.S. housing and defense industries. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar